{"id":72892,"date":"2017-09-28T10:42:34","date_gmt":"2017-09-28T17:42:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2017\/09\/review-of-juvenescence-investing-in-the-age-of-longevity"},"modified":"2017-09-28T10:42:34","modified_gmt":"2017-09-28T17:42:34","slug":"review-of-juvenescence-investing-in-the-age-of-longevity","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2017\/09\/review-of-juvenescence-investing-in-the-age-of-longevity","title":{"rendered":"Review of Juvenescence: Investing in the Age of Longevity"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/review-of-juvenescence-investing-in-the-age-of-longevity.jpeg\"><\/a><\/p>\n<p>Only two years ago, when I launched my advocacy website Rejuvenaction, I didn\u2019t think I would read a book like Juvenescence so soon; yet, the topic of rejuvenation biotechnologies has already become mainstream enough to lead investors of the calibre of Jim Mellon and Al Chalabi to devote a whole book to it.<\/p>\n<p>As Juvenescence is a book aimed at potential new investors in rejuvenation biotechnologies, I expected it to be an extremely technical and detailed account of things I don\u2019t understand, such as finance, markets, and funds. To my delight, this was not the case. Rather, the details Juvenescence dives into are primarily those of the emerging field of rejuvenation science (alas, still something whose details I don\u2019t fully understand).<\/p>\n<p>The book explains the paradigm shift that is currently taking place and changing the way science sees aging\u2014no longer as an inevitable fact of life but rather as a disease to be eradicated like any other\u2014and goes through a biology 101 crash course for the benefit of readers who might be not too well versed in the science of life.<\/p>\n<p><!-- Link: <a href=\"https:\/\/www.leafscience.org\/juvenescence\/\">https:\/\/www.leafscience.org\/juvenescence\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Only two years ago, when I launched my advocacy website Rejuvenaction, I didn\u2019t think I would read a book like Juvenescence so soon; yet, the topic of rejuvenation biotechnologies has already become mainstream enough to lead investors of the calibre of Jim Mellon and Al Chalabi to devote a whole book to it. As Juvenescence [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,45,269],"tags":[],"class_list":["post-72892","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-finance","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/72892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=72892"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/72892\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=72892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=72892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=72892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}